This page records a disagreement over what the respiratory-chain evidence shows. One reading treats Complex I, which oxidises NADH (reduced nicotinamide adenine dinucleotide, a cellular electron carrier), as an aromatic-specific requirement that the flux balance analysis (FBA) model detects as higher flux but misses as essentiality: 1.76× higher Complex I flux alongside 10/13 operon-subunit growth defects 1. An operon is a set of genes transcribed together, and FBA is a constraint-based method that predicts feasible flux distributions. The other reading holds that the strongest defects sit on non-aromatic substrates and in a gene the model routes no flux through: ACIAD3522 has ratios of 0.013 on acetate and 1.39 on quinate and glucose 2. The outcome decides whether elevated model flux can prioritise condition-specific essential genes, a central question for metabolic-model-gapfilling.
Evidence Sides
Side A: Complex I is an aromatic-associated bottleneck that the model under-calls. The aromatic analysis found 1.76× higher Complex I flux but 10/13 operon-subunit growth defects 1. On this reading, the model registers the increased demand on aromatic substrates but does not predict the essentiality that the mutant data show 1.
Side B: The strongest defects are not aromatic-specific, and the model misses them entirely. Fitness defects transferred from orthologs (equivalent genes in other species) were strongest on acetate and succinate rather than exclusively on aromatic substrates 2. ACIAD3522 ratios were 0.013 on acetate and 1.39 on quinate and glucose 2. The synthesis calls this acetate effect, 0.013 on acetate against no defect on quinate (1.39) or glucose (1.39), the largest condition-specific effect of any single gene in the 2,034-gene growth matrix 2. FBA predicts zero flux through ACIAD3522 on all conditions, and the gene’s biological role is unknown 2.
The data also did not support a cross-species compensation hypothesis invoking NDH-2, a single-subunit alternative NADH dehydrogenase, once annotations were corrected. Complex I aromatic deficits were −0.297 in organisms with validated NDH-2 and −0.156 in those without, with p = 0.52, where p is the probability, assuming no true difference, of observing a difference at least this large 2. This is a null result. It does not show that compensation is absent.
Possible Reconciliations
- Hypothesis: Complex I demand tracks NADH flux in general rather than aromatic substrates specifically. Both sides would then describe one high-NADH-flux requirement seen in different substrate panels.
- Hypothesis: Model flux and essentiality are different quantities. A reaction can carry elevated predicted flux without being predicted essential, and a gene predicted to carry zero flux can still be required for growth.
- Hypothesis: Respiratory functions are divided by metabolic regime, with Complex I and ACIAD3522 required under different conditions.
Resolving Work
- Data: direct growth assays of Complex I subunit mutants on acetate, succinate, quinate and glucose in the native organism. Method: per-condition comparison against wild type. Question: are native defects aromatic-specific, or as strong on acetate and succinate as the transferred data suggest?
- Data: ACIAD3522 sequence and genomic context. Method: homology and domain annotation, then adding a candidate reaction to the model. Question: does a mapped reaction reproduce the acetate-specific requirement?
- Data: NDH-2 calls validated beyond text matching across fitness-profiled organisms. Method: a better-powered comparison of Complex I deficits with and without NDH-2. Question: is the p = 0.52 null a matter of statistical power, or a true absence of compensation?
- Data: model flux predictions paired with mutant growth across the 2,034-gene growth matrix. Method: rank correlation (an association measured on ranked rather than raw values) between predicted flux change and observed defect, per condition. Question: does elevated predicted flux forecast condition-specific essentiality at all?